Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

The Zepbound® formulation had a strength of 2.5 mg tirzepatide administered once via injection with the subject monitored over the same eight-day total duration. Blood samples were taken ...

From a special recognition for Purdue engineering at the Indiana Statehouse to Adriana Harmeyer’s return to “Jeopardy!” — Trevor Peters has all the latest Boilermaker news in this week’s edition of ...

These high-quality stocks continuously grow, maintain an edge over competitors, and make more money than the business needs. Want a long-term winner and decades of passive income? Look for companies ...

Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

The researchers collected saliva samples from people with obesity ... compounds similar to the compounds in Mounjaro, Wegovy and Zepbound may work especially well for people with the "hungry ...

Kennedy would need 51 votes in the Senate to be confirmed, but several key Republican lawmakers expressed concerns over his vaccine stance.

Examples include pain or irritation from brushing ... is listed in the literature of some GLP-1 medications but not on Zepbound (tirzepatide). Rosen shared that his patients have reported this ...

Medical experts have long warned about alcohol's risks, and now the drinks industry is embracing sobriety, investing in ...

Let's look at two great examples below. The company is perhaps most known today as one of the leaders in GLP-1 agonists, which treat diabetes (Mounjaro) and obesity (Zepbound) by slowing digestion ...